Dr. Jose De La Cerda, M.D.
What this data tells you about Dr. De La Cerda
Dr. Jose De La Cerda is an urology physician in San Antonio, TX, with 12 years in practice. Based on federal Medicare data, Dr. De La Cerda performed 3,832 Medicare services across 2,093 unique beneficiaries.
Between the years covered by Open Payments, Dr. De La Cerda received a total of $88,157 from 46 pharmaceutical and/or device companies across 401 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. De La Cerda is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Infectious disease DNA/RNA test | 1,017 | $34 | $78 |
| Chronic care management, first 20 min/month | 482 | $39 | $78 |
| Urinalysis with microscopic exam | 413 | $3 | $15 |
| Blood draw (venipuncture) | 342 | $8 | $10 |
| Office visit, established patient (30-39 min) | 237 | $82 | $215 |
| PSA test (prostate cancer screening) | 206 | $18 | $110 |
| Office visit, established patient (20-29 min) | 200 | $58 | $150 |
| Bladder ultrasound after voiding | 189 | $7 | $95 |
| Yeast/candida DNA test | 84 | $34 | $78 |
| Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique | 83 | $34 | $78 |
| Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique | 83 | $34 | $78 |
| Complete ultrasound scan behind abdominal cavity | 80 | $70 | $345 |
| Diagnostic exam of bladder and urethra using an endoscope | 59 | $165 | $490 |
| Testosterone (hormone) level, total | 44 | $25 | $150 |
| New patient office visit (45-59 min) | 37 | $113 | $313 |
| Basic metabolic blood panel | 32 | $8 | $45 |
| Simple insertion of temporary bladder tube | 24 | $47 | $180 |
| Complete blood count (CBC) with differential | 24 | $8 | $25 |
| Initial hospital admission, moderate complexity | 24 | $95 | $275 |
| New patient office visit (30-44 min) | 23 | $77 | $210 |
| Hospital follow-up visit, low complexity | 21 | $38 | $90 |
| Insertion of sacral nerve neurostimulator electrode array | 19 | $274 | $878 |
| Biopsy of prostate gland | 16 | $89 | $350 |
| Ultrasound scan of pelvic region through rectum | 16 | $23 | $285 |
| Chronic care management, additional 20 min/month | 16 | $36 | $92 |
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 16 | $128 | $780 |
| Simple bladder irrigation and/or instillation | 15 | $50 | $215 |
| Psa (prostate specific antigen) measurement, free | 15 | $18 | $150 |
| Analysis for detection of tumor marker | 15 | $20 | $115 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (71%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in urology physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 4% for urology physician in TX.
Geographic Context
3.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. De La Cerda is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (speaking/promotional, top 4%).
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. De La Cerda experienced with infectious disease dna/rna test?
Does Dr. De La Cerda receive payments from pharmaceutical companies?
How do Dr. De La Cerda's costs compare to other urology physicians in San Antonio?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology